{
  "id": 16168923,
  "title": "Hanmi Pharmaceutical’s Next-Generation Obesity Drug Named Zantrutide",
  "url": "https://urgent.news/2026/10/23/hanmi-pharmaceuticals-next-generation-obesity-drug-named-zantrutide",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-23T09:24:05.000Z",
  "source": {
    "name": "Korea IT Times",
    "slug": "korea-it-times",
    "url": "https://www.koreaittimes.com/news/articleView.html?idxno=158470"
  },
  "original_language": "en",
  "account": null,
  "summary": "Hanmi Pharmaceutical has secured an international nonproprietary name (INN) for HM15275, its next-generation obesity drug candidate, which will now be known as zantrutide. The experimental treatment is designed to deliver substantial weight loss while minimizing muscle loss, marking a key component of the company’s strategy to expand its obesity drug pipeline.Hanmi Pharmaceutical, the core…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}